Biopharma intellectual property that is patentable subject matter -- The novelty requirement -- Nonobviousness -- Formal standards of patentability for biopharma inventions -- Restriction and double patenting -- Inequitable conduct: what it is and how to avoid it -- How to write a biopharma patent application -- How and when to file biopharma patent applications -- Identifying the inventors -- Protecting ip rights of nonprofit institutions -- How to prosecute a biopharma patent application -- Post-grant procedures -- Extending the life of a biopharma patent -- Licensing biopharma patents -- Patent infringement -- Statutory infringement of pharmaceutical patents under the Hatch-Waxman Act -- Approval of biologics and the prospect of follow-on biologics -- Assertion of patent infringement in the international trade commission -- Regulatory exclusivities for pharmaceutical products -- Trademark issues relating to pharmaceuticals -- Protection of ip rights by trade secrets -- How to obtain biopharma patents in Canada, China, the European Union, India, and Japan -- Biopharma patent-related regulatory approval provisions in Canada, China, the European Union, India, and Japan -- How to enforce biopharma patents in Canada, China, the European Union -- India, and Japan.
This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.